Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ELI LILLY AND COMPANY

(LLY)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť ELI LILLY AND COMPANY
20/10ELI LILLY AND : FCA And AKS Claim Founded On Free Pharmaceutical Product Education Dismiss..
AQ
19/10ELI LILLY AND : Tirzepatide results published in The Lancet show superior A1C and body wei..
PR
18/10ELI LILLY AND : Lilly Declares Fourth-Quarter 2021 Dividend
PR
14/10ELI LILLY AND : Lilly Announces Updated Verzenioģ (abemaciclib) Phase 3 monarchE Trial Dat..
PR
13/10ELI LILLY AND : FDA Approves Verzenioģ (abemaciclib) as the First and Only CDK4/6 Inhibito..
PR
12/10ELI LILLY AND : Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial R..
PR
07/10ELI LILLY AND : Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI..
PR
01/10ELI LILLY AND : At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Ma..
PR
30/09ELI LILLY AND : Lilly's tirzepatide led to greater improvements in liver fat content compa..
PR
30/09ELI LILLY AND : Lilly's tirzepatide led to greater time in range compared to insulin deglu..
PR
28/09ELI LILLY AND : Lilly again reduces list price of Insulin Lispro Injection as latest chang..
PR
27/09ELI LILLY AND : New Data from Verzenioģ (abemaciclib) monarchE Study to Be Featured in ESM..
PR
25/09ELI LILLY AND COMPANY :  Issues Voluntary Nationwide Recall of One Lot o..
PR
21/09ELI LILLY AND : Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 ..
PR
21/09ELI LILLY AND : Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer ..
PR
21/09ELI LILLY AND : Obviousness Of Method Claim Requires Expectation Of Success For Recited Pu..
AQ
13/09THERMO FISHER SCIENTIFIC : - Oncomine Dx Target Test Receives MHLW Approval as a Companion..
AQ
13/09ELI LILLY AND : Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conferen..
PR
13/09ELI LILLY AND : Lilly to Present New Data from Oncology Portfolio at ESMO Congress
PR
10/09ELI LILLY & CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/09ELI LILLY AND : Lilly Prices First Sustainability Bond to Advance Global ESG Strategy
PR
09/09PROQR THERAPEUTICS N : Announces Conference Call to Discuss the Axiomer RNA Editing Platfo..
AQ
09/09ELI LILLY AND : FDA grants Jardianceģ Breakthrough Therapy designation for heart failure w..
PR
07/09ELI LILLY AND : Lilly Diabetes joins The Leona M. and Harry B. Helmsley Charitable Trust t..
PR
07/09ELI LILLY AND : Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregat..
PR
03/09ELI LILLY AND : Lilly to Participate in the Morgan Stanley 19th Annual Global Healthcare C..
PR
31/08ELI LILLY AND : Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference
PR
30/08ELI LILLY AND : New empagliflozin data shows statistically significant improvement in hear..
AQ
27/08ELI LILLY AND : Landmark trial demonstrates Jardianceģ (empagliflozin) is the first therap..
PR
25/08ELI LILLY AND : Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Boar..
PU
25/08ELI LILLY & CO : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
25/08ELI LILLY AND : Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discove..
PR
18/08ELI LILLY AND : US FDA approves Jardianceģ (empagliflozin) to treat adults living with hea..
PR
17/08ELI LILLY AND : Lilly Announces Leadership Changes and Formation of Neuroscience and Immun..
PU
17/08ELI LILLY & CO : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
17/08ELI LILLY AND : Lilly Announces Leadership Changes and Formation of Neuroscience and Immun..
PR
16/08ELI LILLY AND : FDA approves Lyumjevģ (insulin lispro-aabc injection) 100 units/mL for use..
PR
16/08ELI LILLY AND : Lilly's lebrikizumab significantly improved skin clearance and itch in peo..
PR
04/08BAJAJ HEALTHCARE : Files Compulsory License With Indian Patent Office For Baricitinib
AQ
03/08ELI LILLY AND : & CO Management's Discussion and Analysis of Results of Operations and Fin..
AQ
03/08ELI LILLY AND : Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 ..
PU
03/08ELI LILLY & CO : Results of Operations and Financial Condition, Financial Statements and E..
AQ
03/08ELI LILLY AND : Q2 2021 Lilly Press Release
PU
03/08LILLY : Q2 Earnings Snapshot
AQ
02/08ELI LILLY AND : FCA Upholds Reconsideration Decision Maintaining $100M+ Award Against Apot..
AQ
30/07ELI LILLY AND : FCA Upholds Award Of Compound Interest In Cefaclor Damages Appeal
AQ
29/07ELI LILLY AND : Lilly releases donanemab data that demonstrated relationship between reduc..
PR
29/07ELI LILLY AND : FDA broadens existing emergency use of Lilly and Incyte's baricitinib in p..
PR
29/07ELI LILLY AND : Lilly and Kumquat Biosciences Announce Collaboration to Discover and Devel..
PR
23/07A Guiding Light For The Research Safe Harbor And "Research Tools"?
AQ
22/07ELI LILLY AND : Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial ..
PR
16/07ELI LILLY AND : Lilly and Incyte provide update on supplemental New Drug Application for b..
PR
15/07ELI LILLY AND : Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prev..
PR
14/07ELI LILLY AND : Lilly Announces Acquisition of Protomer Technologies
PR
09/07ELI LILLY AND : Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerati..
PR
06/07ELI LILLY AND : Breakthrough results for Jardianceģ (empagliflozin) confirm EMPEROR-Preser..
PR
01/07ELI LILLY AND : Lilly Diabetes Update at ADA Presentation
PU
29/06ELI LILLY AND : Lilly Declares Third-Quarter 2021 Dividend
PR
24/06Eli Lilly, Steelcase rise; KB Home, H.B. Fuller fall
AQ
24/06ELI LILLY AND : Lilly to seek FDA approval for potential Alzheimer's drug
AQ
24/06ELI LILLY AND : Lilly announces call for Leonard Award nominations as part of global initi..
PR
24/06ELI LILLY AND : Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for..
PR
14/06ELI LILLY AND : Lilly to Participate in Guggenheim Biopharma Strategy Series
PR
14/06Fiserv Appoints Wafaa Mamilli to Board of Directors
AQ
11/06ELI LILLY AND : Thinking about trading options or stock in Crispr Therapeutics, AMC, Atome..
PR
03/06ELI LILLY AND : Lilly to Participate in Goldman Sachs Healthcare Conference
PR
02/06ELI LILLY AND : Taltzģ Showed Consistent, Long-Term Improvement in Key Signs and Symptoms ..
PR
28/05DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational New Drug (IN..
AQ
27/05ELI LILLY & CO : Other Events (form 8-K)
AQ
22/05ELI LILLY AND : Mirikizumab Improves Fatigue in Patients with Crohn's Disease in Phase 2 T..
PR
18/05ELI LILLY AND : U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with ..
PR
13/05ELI LILLY AND : Lilly to Participate in UBS Global Healthcare Virtual Conference
PR
13/05Push for Covid-19 Vaccine Patent Waiver Isn't a Panacea - but It Could Nudge Companies ..
AQ
11/05ELI LILLY AND : Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
PR
06/05ELI LILLY AND : Lilly collaborates internationally with leading diabetes technology compan..
PR
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ELI LILLY AND COMPANY
26/10/21